Trade

with

Pharmerica Corp
(NYSE: PMC)
AdChoices
27.48
+0.12
+0.44%
After Hours :
27.48
0.00
0.00%

Open

27.45

Previous Close

27.36

Volume (Avg)

166.58k (229.70k)

Day's Range

27.33-27.63

52Wk Range

14.29-30.48

Market Cap.

826.06M

Dividend Rate ( Yield )

-

Beta

1.20

Shares Outstanding

30.06M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Pharmaceutical Retailers
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 1.76B

    • Net Income

    • 18.90M

    • Market Cap.

    • 826.06M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -0.37

    • PEG (Price/Earnings Growth) Ratio

    • 1.02

    • Beta

    • 1.20

    • Forward P/E

    • 15.04

    • Price/Sales

    • 0.46

    • Price/Book Value

    • 1.79

    • Price/Cash flow

    • 13.77

      • EBITDA

      • 90.50M

      • Return on Capital %

      • -0.76

      • Return on Equity %

      • -1.44

      • Return on Assets %

      • -0.76

      • Book Value/Share

      • 15.38

      • Shares Outstanding

      • 30.06M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 26.00

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • 1.81

        • Cashflow Estimate

        • 3.12

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 4.10

          • 5.83

          • Net Income

            YTD/YTD (last year)

          • -17.50

          • 40.13

          • Net Income

            Q/Q (last year)

          • -

          • 21.21

          • Sales (Revenue)

            5-Year Annual Average

          • -2.03

          • 24.54

          • Net Income

            5-Year Annual Average

          • 30.50

          • 3.99

          • Dividends

            5-Year Annual Average

          • -

          • 7.27

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 18.00

            • 28.49

            • Pre-Tax Margin

            • 0.29

            • 5.76

            • Net Profit Margin

            • -0.37

            • 3.69

            • Average Gross Margin

              5-Year Annual Average

            • 15.40

            • 28.40

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 2.30

            • 5.17

            • Average Net Profit Margin

              5-Year Annual Average

            • 1.40

            • 216.91B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.55

              • 0.20

              • Current Ratio

              • 3.47

              • 1.43

              • Quick Ratio

              • 1.66

              • 0.61

              • Interest Coverage

              • -

              • 1.80

              • Leverage Ratio

              • 2.00

              • 1.79

              • Book Value/Share

              • 15.38

              • 9.14

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -121.95

                • 28.74

                • P/E Ratio 5-Year High

                • -135.19

                • 150.74

                • P/E Ratio 5-Year Low

                • -30.52

                • 39.16

                • Price/Sales Ratio

                • 0.46

                • 0.65

                • Price/Book Value

                • 1.79

                • 3.42

                • Price/Cash Flow Ratio

                • 13.77

                • 13.95

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -1.44

                    (6.50)

                  • 14.11

                    (14.89)

                  • Return on Assets %

                    (5-Year Average)

                  • -0.76

                    (3.30)

                  • 7.70

                    (7.85)

                  • Return on Capital %

                    (5-Year Average)

                  • -0.92

                    (3.40)

                  • 11.17

                    (12.16)

                  • Income/Employee

                  • -

                  • 9.23k

                  • Inventory Turnover

                  • 11.52

                  • 8.00

                  • Asset Turnover

                  • 2.02

                  • 2.09

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  55.80M
                  Operating Margin
                  3.17
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  13.77
                  Ownership

                  Institutional Ownership

                  96.58%

                  Top 10 Institutions

                  37.24%

                  Mutual Fund Ownership

                  49.26%

                  Float

                  96.63%

                  5% / Insider Ownership

                  6.60%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • iShares Core S&P Small-Cap (AU)

                  •  

                    609,371

                  • 0.20

                  • 2.27

                  • Columbia Small Cap Value Fund II

                  •  

                    597,900

                  • 0.00

                  • 1.99

                  • DFA US Small Cap Value II Portfolio

                  •  

                    581,609

                  • 1.32

                  • 1.93

                  • Fidelity® Advisor Small Cap Opps Fund

                  •  

                    484,216

                  • 14.63

                  • 1.61

                  • Vanguard Total Stock Mkt Idx

                  •  

                    466,624

                  • 1.50

                  • 1.55

                  • iShares Russell 2000 (AU)

                  •  

                    448,112

                  • -1.46

                  • 1.67

                  • Vanguard Explorer Fund

                  •  

                    406,585

                  • 78.60

                  • 1.35

                  • JNL/Mellon Cptl S&P SMid 60 Fund

                  •  

                    312,581

                  • -9.36

                  • 1.04

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Dimensional Fund Advisors, Inc.

                  •  

                    2,185,759

                  • +6.59%

                  • 7.27

                  • BlackRock Fund Advisors

                  •  

                    1,711,413

                  • -3.91%

                  • 5.69

                  • Vanguard Group, Inc.

                  •  

                    1,243,275

                  • +8.34%

                  • 4.14

                  • LSV Asset Management

                  •  

                    1,102,294

                  • -23.45%

                  • 3.67

                  • Acadian Asset Management LLC

                  •  

                    941,560

                  • -21.59%

                  • 3.13

                  • Fidelity Management and Research Company

                  •  

                    883,334

                  • -30.55%

                  • 2.94

                  • Columbia Mangmt Investment Advisers, LLC

                  •  

                    873,187

                  • +3.35%

                  • 2.90

                  • Munder Capital Management

                  •  

                    726,969

                  • +51.00%

                  • 2.42

                  • Merrill Lynch & Co Inc

                  •  

                    694,560

                  • -2.15%

                  • 2.31

                  Company Profile

                  Sector

                  Consumer Defensive

                  Industry

                  Pharmaceutical Retailers

                  Type

                  Slow Growth

                  Style

                  Small Value

                  Pharmerica Corp a Delaware Corporation was formed on October 23, 2006. The Company is an institutional pharmacy services company that services healthcare facilities, provides pharmacy management services to hospitals, provides specia...morelty infusion services to patients outside a hospital setting, and offers the national oncology pharmacy in the United States. It operates 96 institutional pharmacies and 12 specialty infusion centers and 5 specialty oncology pharmacies in 45 states. Its customers comprises of institutional healthcare providers, such as skilled nursing facilities, nursing centers, assisted living facilities, hospitals, individuals receiving in-home care and other long-term alternative care providers. The Company's core business provides pharmacy products and services to residents and pati...moreents in skilled nursing facilities, nursing centers, assisted living facilities, hospitals, and other long-term alternative care settings. It purchases, repackages, and dispenses prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers such medication to healthcare facilities for administration to individual patients and residents. The Company operates in three segments; pharmacy, specialty infusion services, and speciality oncology pharmacy. It sells its products and services through a national sales force. On a nationwide basis, the Company competes with institutional pharmacy industry, Omnicare. The Company is subject to federal and state laws that regulate financial arrangements between healthcare providers, including the federal anti-kickback statutes and the federal physician self-referral laws.lessless

                  Key People

                  Gregory S. Weishar

                  CEO/Director

                  Mr. Geoffrey G. Meyers

                  Chairman of the Board/Director

                  David W. Froesel,Jr

                  CFO/Executive VP/Treasurer

                  Suresh Vishnubhatla

                  Executive VP, Divisional

                  Frank E. Collins,Esq.,J.D.

                  Director

                  • Pharmerica Corp

                  • 1901 Campus Place

                  • Louisville, KY 40299

                  • USA.Map

                  • Phone: +1 502 627-7000

                  • Fax: -

                  • pharmerica.com

                  Incorporated

                  2006

                  Employees

                  5,800

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: